GE Hitachi Nuclear Energy, BWXT Canada and Synthos Green Energy Announce Intention to Support Deployment of Small Modular Reactors in Poland
CAMBRIDGE, ONTARIO—December 15, 2021—GE Hitachi Nuclear Energy (GEH), BWXT Canada Ltd. (BWXT Canada) and Synthos Green Energy (SGE) today announced their intention to cooperate in deploying BWRX-300 small modular reactors (SMR) in Poland.
BWXT Delivers Fuel to NASA to Support Nuclear Thermal Propulsion
(LYNCHBURG, Va. – Dec. 13, 2021) – BWX Technologies, Inc. (NYSE: BWXT) has reached a critical milestone in the nation’s pursuit of space nuclear propulsion by delivering coated reactor fuels to NASA in support of its space nuclear propulsion project within the agency’s Space Technology Mission Directorate.
BWXT Names Joey Hoskins as Vice President, Business Development
BWXT Hosting Investor Day on Nov. 16
(LYNCHBURG, Va. – Nov. 15, 2021) – BWX Technologies, Inc. (NYSE: BWXT) is hosting an Investor Day 8:30 a.m. to approximately 11:30 a.m. ET on Tuesday, Nov. 16, 2021.
BWXT Names Robb A. LeMasters as Next Chief Financial Officer
Current CFO David Black to Retire After 30 Years at BWXT and Serve as Special Advisor to CEO.
OPG awards contract for complex parts for nuclear refurbishment
Peterborough – Ontario Power Generation (OPG) and BWX Technologies, Inc. (NYSE: BWXT) are announcing a contract for Fuelling Machine (FM) head engineering and component supply as part of refurbishment of the Darlington Nuclear Generating Station.
BWX Technologies Reports Third Quarter 2021 Results, Narrows 2021 Guidance and Strategically Deploys Capital to Repurchase Shares
BWXT Awarded $21 Billion Environmental Management Contract for DOE’s Savannah River Site
(LYNCHBURG, Va. – Oct. 28, 2021) – BWX Technologies, Inc. (NYSE: BWXT) today announced a contract with an estimated ceiling of approximately $21 billion over a 10-year ordering period from the U.S. Department of Energy (DOE) for environmental management operations at the Savannah River Site (SRS) in South Carolina.
BWXT Medical and Bayer AG Enter into Agreement for the Development and Production of Actinium-225
(OTTAWA, Ontario – September 16, 2021) – BWX Technologies, Inc. (NYSE: BWXT) announced today that its BWXT Medical Ltd. subsidiary (BWXT Medical) has entered into an agreement with Bayer AG (Bayer) to develop Actinium-225 (Ac-225) supply and further partnering opportunities on finished products as both companies broaden their respective commercialization strategies for targeted radionuclide therapies (TRTs) and other innovative products.
BWXT Awarded CA$40 Million Contract to Supply Heat Exchangers for Bruce Power
BWX Technologies, Inc. (NYSE: BWXT) today announced a contract from Bruce Power valued at approximately CA$40 million to supply four moderator heat exchangers.